Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
103 Cards in this Set
- Front
- Back
LN:
medullary cords contain |
plasma cells
|
|
LN:
medullary sinuses contain (2) |
reticular cells
macrophages |
|
LN:
paracortex contains |
T cells
|
|
B-cells and T-cells enter LN from blood through
|
HEV's
|
|
LN:
enlarged during a cellular immune response |
paracortex (site of T cells)
|
|
LN:
not well developed in DiGeorge syndrome |
paracortex (site of T cells)
|
|
right lymphatic duct drains (2)
|
right arm
right 1/2 of head |
|
spleen:
white pulp contains |
B cells
|
|
spleen:
periarterial lymphatic sheath (PALS) contains |
T-cells
|
|
spleen:
red pulp contains |
T cells
|
|
thymus:
cortex contains |
immature T cells
|
|
thymus:
medulla contains (3) |
mature T cells
epithelial reticular cells Hassall's corpuscles |
|
thymus:
positive and negative selection of T cells occurs at the |
corticomedullary junctions
|
|
helper T cells release _______ to stimulate production of Th1 cells
|
IL-1 through IL-12
|
|
helper T cells release ______ to stimulate production of Th2 cells
|
IL-1 through IL-4
|
|
Th1 cells release (2)
|
IL-2
IFN-γ |
|
Th1 cells activate (2)
|
cytotoxic T cells
macrophages |
|
Th2 cells release (2)
|
IL-4
IL-5 |
|
Th2 cells activate
|
B cells (to stimulate Ab production; IgE > IgG)
|
|
MHC I is expressed on
|
nucleated cells
|
|
antigen for MHC I is loaded in
|
RER
|
|
MHC II is expressed on
|
antigen presenting cells (APC's)
|
|
antigen for MHC II is loaded in
|
acidified endosome
|
|
main determinant of organ rejection
|
MHC II
|
|
MHC I is made of
|
α and β-2 microglobulin
|
|
MHC II is made of
|
α and β
|
|
directly kills viruses
|
cytotoxic T cells
|
|
APC's (3)
|
dendritic cells
macrophages B cells |
|
APC's stimulate CD4 T-cells using
|
IL-1
|
|
costimulatory signal required for Th cell activation
|
B7 (APC) + CD28 (CD4 T cell)
|
|
Th cells activate cytotoxic T cells using
|
IL-2
|
|
function of terminal deoxynucleotidul transferase
|
adds nucleotides to DNA during genetic recombination
(increases Ab diversity) |
|
mature B lymphocytes express (2)
|
IgM
IgD |
|
isotype switching is mediated by (2)
|
CD40
cytokines |
|
IL:
secreted by macrophages (3) |
IL-1
IL-6 IL-12 |
|
in addition to IL-1, IL-6, and IL-12, macrophages also secrete
|
TNF-α
|
|
IL:
stimulates T cells, B cells, neutrophils, fibroblasts, and epithelial cells an endogenous pyrogen |
IL-1
(HOT T-Bone stEAk) |
|
IL:
stimulates growth of helper T cells and cytotoxic T cells |
IL-2
(HOT T-Bone stEAk) |
|
IL:
supports growth and differentiation of bone marrow stem cells, i.e., has a function similar to GM-CSF |
IL-3
(HOT T-Bone stEAk) |
|
IL:
promotes growth of B cells enhances class switching of IgE and IgG |
IL-4
(HOT T-Bone stEAk) |
|
IL:
promotes differentiation of B cells stimulates production and activation of eosinophils enhances class switching of IgA |
IL-5
(HOT T-Bone stEAk) |
|
IL:
stimulates production of acute-phase reactants and Ig's |
IL-6
|
|
IL:
major chemotatic factor for neutrophils |
IL-8
(lobes of neutrophils look like an "8") |
|
IL:
stimulates Th2 cells inhibits Th1 cells |
IL-10
|
|
IL:
stimulates Th1 cells activates NK cells |
IL-12
|
|
IFN:
stimulates macrophages |
IFN-γ
(γ causes macrophages to gobble) |
|
TNF:
causes an increase in IL-2 receptor synthesis by Th cells increases B-cell proliferation attracts and activates neutrophils stimulates dendritic cell migration to LN's |
TNF-α
|
|
cell surface proteins:
helper T cells (5) |
TCR
CD3 CD4 CD28 CD40L |
|
cell surface proteins:
cytotoxic T cells (3) |
TCR
CD3 CD8 |
|
cell surface proteins:
B cells (6) |
MHC II (B cell is an APC)
B7 (part of co-stimulatory signal) IgM CD19 CD20 |
|
cell surface proteins:
macrophages (4) |
MHC II (macrophage is an APC)
Fc receptor C3b receptor CD14 |
|
cell surface proteins:
NK cells (3) |
MHC I receptor
CD16 CD56 |
|
cell surface proteins:
all cells except mature RBC's |
MHC I (all nucleated cells have MHC I)
|
|
complement activated by:
classic pathway |
IgM
IgG (Ag-Ab complexes activate complement) |
|
complement activated by:
alternative pathway |
molecules found on surface of microbes (esp. exotoxin)
|
|
opsonins in bacterial defense (2)
|
C3b
IgG |
|
complement components:
viral neutralization pathway |
C1
C2 C3 C4 classic |
|
complement component:
opsonization |
C3b
|
|
complement components:
anaphylaxis |
C3a
C5a (together with C3a) |
|
complement components:
neutrophil chemotaxis |
C5a (alone)
|
|
complement components:
MAC |
C5b
C6 C7 C8 C9 |
|
complement component:
alternative pathway and classic pathway merge at |
C5
|
|
hereditary angioedema caused by
|
C1 esterase inhibitor deficiency (overactive bradykinin --> increased bv permeability)
|
|
severe, recurrent pyogenic sinus and respiratory tract infections caused by
|
C3 deficiency
|
|
Neisseria bacteremia caused by
|
C6, C7 and/or C8 deficiency
|
|
PNH caused by
|
deficiency of decay-accelerating factor (DAF)
|
|
place uninfected cells in an antiviral state
|
IFN's
|
|
IFN's induce produce of _______ to ward off viruses
function |
ribonuclease
degrades viral mRNA |
|
IFN's:
inhibit viral protein synthesis |
IFN-α
IFN-β |
|
IFN:
increases MHC I and II expression and antigen presentation |
IFN-γ
|
|
NK cells activated to kill virus-infected via
|
IFN's
|
|
preformed Ab's given after exposure to (4)
|
tetanus toxin
botulinum toxin HBV rabies (To Be Healed Rapidly) |
|
antigen variation:
salmonella |
2 flagellar variants
|
|
antigen variation --> relapsing fever
|
Borrelia
|
|
antigen variation:
Neisseria gonorrhoeae |
pilus protein
|
|
parasite that demonstrates antigen variation
mechanism |
Trypanosome
programmed rearrangement |
|
anergy (def.)
|
self-reactive T cells become nonreactive if they don't receive a costimulatory molecule
|
|
hypersensitivity reaction:
involves attraction of neutrophils |
type III
|
|
hypersensitivity reaction:
involves macrophage activation |
type IV
|
|
hypersensitivity reaction:
PAN |
type III
|
|
hypersensitivity reaction:
hypersensitivity pneumonitis |
type III
|
|
hypersensitivity reaction:
MS |
type IV
|
|
hypersensitivity reaction:
Guillain-Barre |
type IV
|
|
hypersensitivity reaction:
GVHD |
type IV
|
|
disorder:
antihistone |
drug-induced lupus (aks lupus-like syndrome)
|
|
disorder:
antimicrosomal |
Hashimoto's thyroiditis
|
|
disorders (2):
anti-Jo-1 |
dermatomyositis
polymyositis |
|
HLA subtype:
psoriasis |
HLA-B27
|
|
HLA subtype:
inflammatory bowel disease (IBD) |
HLA-B27
|
|
HLA subtype:
Graves' disease |
HLA-B8
|
|
HLA subtype:
celical sprue |
HLA-B8
|
|
HLA subtype:
MS |
HLA-DR2
|
|
HLA subtype:
hay fever |
HLA-DR2
|
|
HLA subtype:
SLE |
HLA-DR2
|
|
HLA subtype:
Goodpasture's syndrome |
HLA-DR2
|
|
HLA subtype:
pernicious anemia |
HLA-DR5
|
|
HLA subtype:
Hashimoto's thyroiditis |
HLA-DR5
|
|
HLA subtype:
steroid-responsive nephrotic syndrome |
HLA-DR7
|
|
hyperacute transplant rejection:
due to occurs within |
preformed antidonor Ab's
minutes |
|
acute transplant rejection:
due to occurs within reversible? |
cytotoxic T lymphocytes react against foreign MHC's
weeks yes |
|
acute transplant rejection is treated with (2)
|
cyclosporin
OKT3 |
|
chronic transplant rejection:
due to occurs within reversible? |
Ab-mediated vascular damage --> fibrinoid necrosis
months to years no |
|
GVHD:
due to signs (4) |
grafted immunocompetent T cells attack host proteins
maculopapular rash jaundice hepatosplenomegaly diarrhea |